Stocks · Healthcare · Medical - Healthcare Information Services
Tempus AI, Inc. TEM
$76.63 +0.17% Close, Oct 2, 2026 · NASDAQ · Market cap $13.43B
High risk
Next earnings report: Nov 3, 2026
Scroll or pinch to zoom, drag to move. Daily prices adjusted for splits. Markers: E = earnings (green beat, red miss), S = split, D = dividend.
Three things to know
- Revenue over the last four quarters was $1.43B, up 50.4% from a year earlier, slowing from 69.8% a quarter earlier.
- Earnings beat analyst estimates in each of the last 6 quarters (average surprise over the last four: +38.7%).
- The stock is in an uptrend: above its 200-day average for 32 trading days, with the 50-day average above the 200-day.
PromtFinance scores
Each score is a percentile within the Healthcare sector (0–100). Under each score: how the stock ranks in its sector on every component. As of Oct 5, 2026.
How fast revenue, earnings and cash flow are growing.
- Revenue growth (TTM, YoY)Top 17%
- Revenue growth, 3-year CAGRTop 11%
- Revenue growth accelerationBottom 12%
Returns on capital, margins, earnings quality and balance-sheet strength.
- Return on invested capitalTop 45%
- Gross marginBottom 49%
- Operating marginBottom 43%
- Accruals (lower is better)Bottom 19%
- Interest coverBottom 41%
How cheap the shares are relative to earnings, cash flow and their own history.
- Earnings yieldTop 35%
- Free-cash-flow yieldTop 43%
- EBITDA / enterprise valueTop 39%
- Sales / enterprise valueBottom 31%
Strength and persistence of the price trend, including versus the S&P 500.
- 12-month return excluding last monthBottom 18%
- 6-month returnTop 16%
- 1-year return vs S&P 500Bottom 34%
- Distance from 52-week highTop 42%
- Trend checklist (0–4)Top 7%
Earnings surprises and analyst sentiment (estimate-revision history is being collected).
- Average EPS surprise, last 4 quartersTop 15%
- Consecutive EPS beatsTop 12%
- Share of analysts rating BuyBottom 30%
- Upside to consensus price targetBottom 8%
Low volatility, shallow drawdowns, low market sensitivity and modest leverage.
- Volatility, 60 days (lower is better)Bottom 12%
- Maximum drawdown, 3 yearsTop 34%
- Beta vs S&P 500 (lower is better)Bottom 2%
What changed
Latest four quarters versus the same period a year earlier (growth: versus one quarter earlier).
| Measure | Before | Now | |
|---|---|---|---|
| Revenue growth (YoY) | 69.8% | 50.4% | ↓ |
| Gross margin | 60.7% | 64.0% | ↑ |
| Operating margin | -24.7% | -19.8% | ↑ |
| FCF margin | -7.7% | -19.1% | ↓ |
Fundamental momentum
| Measure | Now (TTM) | Year / quarter before | Sector rank | |
|---|---|---|---|---|
| Revenue growth (TTM, YoY) | 50.4% | 69.8% | ↓ | Top 17% |
| Gross margin | 64.0% | 60.7% | ↑ | Bottom 49% |
| Operating margin | -19.8% | -24.7% | ↑ | Bottom 43% |
| Net margin | -17.8% | -21.0% | ↑ | — |
| Free-cash-flow margin | -19.1% | -7.7% | ↓ | — |
| Return on invested capital | -13.9% | — | Top 45% | |
| Revenue growth, 3-year CAGR | 58.3% | — | Top 11% |
Quality of earnings and balance sheet
- Accruals (net income − OCF) / assetsLower is better; high accruals can signal weaker earnings quality.
- -0.7%
- Stock-based compensation / revenueA cost to shareholders through dilution.
- 13.0%
- Receivables growth vs revenue growthReceivables growing much faster than sales can be a warning.
- -9.7 pp
- Interest cover (operating income / interest)How many times operating profit covers interest.
- -5.1×
Shareholder returns
- Dividend yield (dividends paid, TTM)
- 0.00%
- Net buyback yield (TTM)
- -1.43%
- Shareholder yield
- -1.43%
- Share count change, 1 year
- +5.2%
- Share count change, 3-year CAGR
- +2.4%
Shareholder yield = dividends + net buybacks over the last four quarters, divided by market cap.
Based on the four quarters through Jun 30, 2026 (filed Jul 30, 2026).
Earnings and expectations
Earnings momentum
- Consecutive EPS beats
- 6
- Beats in the last 8 reports
- 7 of 8
- Average EPS surprise, last 4
- +38.7%
- Average 2-day reaction, last 8
- +1.2%
- Positive 20 days after report
- 4 of 8
Analysts
- Consensus price target
- $72.60
- Target vs current price
- -5.3%
- Analysts with a rating
- 14
- Share rating Buy or Strong Buy
- 64%
- Consensus rating
- Buy
How the stock reacted to recent reports
| Report date | EPS surprise | 2 days | 5 days | 20 days | 60 days |
|---|---|---|---|---|---|
| Jul 30, 2026 | +72.0% | +6.6% | +12.4% | +64.8% | — |
| May 5, 2026 | +38.1% | -3.1% | -13.2% | -11.1% | -20.6% |
| Feb 24, 2026 | +8.8% | +1.2% | -6.9% | -14.2% | -20.5% |
| Nov 4, 2025 | +36.2% | -4.8% | -19.1% | -16.6% | -32.6% |
| Aug 8, 2025 | +4.3% | +3.6% | +21.9% | +35.5% | +53.0% |
| May 6, 2025 | +7.7% | -3.5% | +15.9% | +14.6% | +4.7% |
| Feb 24, 2025 | -20.0% | +2.2% | -17.5% | -24.6% | -6.4% |
| Nov 4, 2024 | +6.0% | +7.5% | +60.2% | +36.6% | +24.6% |
Returns from the close before each report. Past reactions do not determine future ones.
Earnings history
| Report date | EPS | Estimate | Surprise | Revenue |
|---|---|---|---|---|
| Jul 30, 2026 | -$0.04 | -$0.14 | +72.0% | $382.5M |
| May 5, 2026 | -$0.13 | -$0.21 | +38.1% | $348.1M |
| Feb 24, 2026 | -$0.04 | -$0.04 | +8.8% | $367.2M |
| Nov 4, 2025 | -$0.11 | -$0.17 | +36.2% | $334.2M |
| Aug 8, 2025 | -$0.22 | -$0.23 | +4.3% | $314.6M |
| May 6, 2025 | -$0.24 | -$0.26 | +7.7% | $255.7M |
| Feb 24, 2025 | -$0.18 | -$0.15 | -20.0% | $200.7M |
| Nov 4, 2024 | -$0.25 | -$0.27 | +6.0% | $180.9M |
Valuation in context
| Multiple | Now | 5-year median | 5-year percentile | Sector rank (cheapness) |
|---|---|---|---|---|
| EV / Sales | 9.97× | — | — | Bottom 31% |
| Free-cash-flow yield | -2.03% | — | — | Top 43% |
| Earnings yield | -1.88% | — | — | Top 35% |
Technical state
Trend checklist
- ✓ Price above 20-day average
- ✓ Price above 50-day average
- ✓ Price above 200-day average
- ✓ 50-day average above 200-day
- ✗ MACD histogram positive
Trend quality
- Days above the 50-day average
- 32
- Days above the 200-day average
- 32
- 50-day average slope (20 days)
- +12.7%
- 200-day average slope (20 days)
- +0.0%
- Distance from 50-day average
- +22.5%
- Distance from 200-day average
- +35.8%
- RSI (14)
- 56.6
- Relative volume
- 0.83×
Risk and drawdowns
- Volatility, 60 days (annualized)
- 90.2%
- Volatility vs own 5-year history
- 54th percentile · Normal for this stock
- Beta vs S&P 500 (2 years, weekly)
- 2.91
- Correlation with S&P 500
- 0.42
- Current drawdown from 1-year high
- -25.8%
- Maximum drawdown, 3 years
- -59.8%
Largest declines in the past six years
| From peak | To low | Decline | Length | Recovery |
|---|---|---|---|---|
| Oct 8, 2025 | Jul 29, 2026 | -59.8% | 201 days | Not yet recovered |
| Nov 11, 2024 | Jan 14, 2025 | -59.0% | 42 days | 21 days (Feb 13, 2025) |
| Feb 14, 2025 | Apr 8, 2025 | -58.4% | 36 days | 123 days (Oct 3, 2025) |
| Aug 21, 2024 | Oct 28, 2024 | -39.4% | 47 days | 9 days (Nov 8, 2024) |
| Jun 14, 2024 | Jun 25, 2024 | -38.0% | 6 days | 14 days (Jul 16, 2024) |
Declines of 10% or more from a closing high, measured on daily closes.
Financial statements
- Market cap
- $13.43B
- EPS, diluted (TTM)
- -$1.44
- Revenue (TTM)
- $1.43B
- 52-week range
- $40.77 – $104.32
| FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|
| Revenue | $257.9M | $320.7M | $531.8M | $693.4M | $1.27B |
| Gross profit | $83.6M | $130.2M | $286.2M | $381.1M | $797.9M |
| Operating income | -$243.7M | -$265.4M | -$196.1M | -$691.1M | -$252.9M |
| Net income | -$259.2M | -$289.8M | -$214.1M | -$705.8M | -$245.0M |
| EPS (diluted) | -$1.75 | -$1.97 | -$1.73 | -$4.60 | -$1.41 |
| Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | Q1 2026 | Q2 2026 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $180.9M | $200.7M | $255.7M | $314.6M | $334.2M | $367.2M | $348.1M | $382.5M |
| Net income | -$75.8M | -$13.0M | -$68.0M | -$42.8M | -$80.0M | -$54.2M | -$125.9M | $5.6M |
| EPS (diluted) | -$0.46 | -$0.08 | -$0.40 | -$0.25 | -$0.46 | -$0.30 | -$0.71 | $0.03 |
| FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|
| Operating cash flow | -$212.0M | -$168.2M | -$214.3M | -$189.0M | -$218.1M |
| Capital expenditure | -$11.8M | -$18.4M | -$34.6M | -$22.1M | -$27.3M |
| Free cash flow | -$223.8M | -$186.6M | -$248.9M | -$211.2M | -$245.4M |
| Dividends paid | -$5.6M | -$5.6M | -$5.6M | -$5.6M | $0 |
| Net share buybacks | $0 | $0 | -$3.6M | $382.0M | $192.5M |
Cash outflows are shown as negative numbers.
- Cash and short-term investments
- $816.0M
- Total assets
- $2.37B
- Total liabilities
- $1.92B
- Total debt
- $1.44B
- Net debt
- $844.6M
- Shareholders’ equity
- $444.9M
As of Jun 30, 2026 (filed Jul 30, 2026).
Short interest
- Shares sold short
- 28,059,350
- Days to cover
- 5.16
- Change vs previous report
- -4.8%
FINRA short interest, settlement date Sep 15, 2026.